Drugs / HSV-2 mRNA Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07330440 | Oct 2025 → Mar 2027 expected | genital herpes | Changchun BCHT Biotechnology Co. | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HSV-2 mRNA Vaccine | “HSV-2 mRNA Vaccine” NCT07330440 ↗ |
| Modality | Messenger RNA (mRNA) | “HSV-2 mRNA Vaccine” NCT07330440 ↗ |